Revance Therapeutics Inc (RVNC)
3.275
-0.30
(-8.26%)
USD |
NASDAQ |
Apr 25, 16:00
3.35
+0.08
(+2.29%)
After-Hours: 20:00
Revance Therapeutics Profit Margin (Quarterly): -79.80% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -79.80% |
| September 30, 2023 | -248.7% |
| June 30, 2023 | -115.7% |
| March 31, 2023 | -121.2% |
| December 31, 2022 | -292.4% |
| September 30, 2022 | -291.9% |
| June 30, 2022 | -217.7% |
| March 31, 2022 | -254.7% |
| December 31, 2021 | -243.2% |
| September 30, 2021 | -376.7% |
| June 30, 2021 | -383.9% |
| March 31, 2021 | -538.7% |
| December 31, 2020 | -703.4% |
| September 30, 2020 | -2.12K% |
| June 30, 2020 | -20.26K% |
| March 31, 2020 | -106.8K% |
| December 31, 2019 | -50.93K% |
| September 30, 2019 | -90.02K% |
| June 30, 2019 | |
| March 31, 2019 | -12.70K% |
| December 31, 2018 | -8.34K% |
| September 30, 2018 | -1.39K% |
| June 30, 2018 | -4.97K% |
| Date | Value |
|---|---|
| March 31, 2018 | -18.15K% |
| December 31, 2017 | -97.05K% |
| September 30, 2017 | -40.87K% |
| June 30, 2017 | -35.83K% |
| March 31, 2017 | -36.21K% |
| December 31, 2016 | -35.74K% |
| September 30, 2016 | -23.97K% |
| June 30, 2016 | -32.80K% |
| March 31, 2016 | -26.52K% |
| December 31, 2015 | -29.46K% |
| September 30, 2015 | -25.57K% |
| June 30, 2015 | -22.41K% |
| March 31, 2015 | -20.54K% |
| December 31, 2014 | -18.95K% |
| September 30, 2014 | -18.64K% |
| June 30, 2014 | -17.74K% |
| March 31, 2014 | -13.56K% |
| December 31, 2013 | -3.26K% |
| September 30, 2013 | -5.62K% |
| June 30, 2013 | -15.77K% |
| March 31, 2013 | -28.88K% |
| December 31, 2012 | -9.32K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-106.8K%
Minimum
Mar 2020
-79.80%
Maximum
Dec 2023
-15.22K%
Average
-334.5%
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie Inc | 5.75% |
| Alnylam Pharmaceuticals Inc | -31.35% |
| Ionis Pharmaceuticals Inc | -2.85% |
| Madrigal Pharmaceuticals Inc | -- |
| Vertex Pharmaceuticals Inc | 38.48% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -59.15% |
| Return on Invested Capital | -92.45% |
| Gross Profit Margin (Quarterly) | 74.97% |
| Operating Margin (Quarterly) | -76.54% |
| Return on Net Operating Assets | -159.7% |